Accro Bioscience Begins Phase IIb Trials for Promising UC Treatment AC-101 #USA #New_York #Ulcerative_Colitis #AC-101 #Accro_Bioscience

Accro Bioscience Begins Phase IIb Trials for Promising UC Treatment AC-101 #USA #New_York #Ulcerative_Colitis #AC-101 #Accro_Bioscience
Accro Bioscience's AC-101 Tablets Join NMPA's Rare Disease Development Initiative #China #Suzhou #AC-101 #Accro_Bioscience #Blau_syndrome
Accro Bioscience Secures IND Approval for Vitiligo Treatment Trial in China #China #Suzhou #Fosun_Pharma #AC-201 #Accro_Bioscience